Home | Pharma Manufacturing

Pharma’s new age of longevity

Novel therapeutic approaches to aging are creating a healthspan market with staying power

Be Sure To Read

Melting schizophrenia treatment barriers

Drugmakers are developing drugs that target different neurotransmitter systems, providing effective, long-acting treatments with fewer side effects and improved adherence

Pharma's molecular glue garden

With key players entering the ring and many clinical trials underway, the molecular glue garden is bound to bloom soon

Notable 2024 FDA decisions

A look at consequential drug approvals and rejections from this year

Harnessing the power of bispecific antibodies

With increased pharma partnerships, FDA approvals and positive market trends, bispecific antibodies are here to stay

Virginia is for pharma lovers

Richmond has rebounded from its tobacco breakup and is courting a serious relationship with advanced manufacturing technology

Mining pharma's reshoring rush

It’s time for the U.S. to sift through domestic drug manufacturing efforts

Industry News

Lundbeck acquires Longboard Pharmaceuticals in $2.6B neuro deal

Longboard’s lead drug, bexicaserin, is currently in late-stage trials for treating rare forms of epilepsy

Pfizer, Triana ink molecular glue degrader partnership

Triana is set to receive $49 million upfront, with potential milestone payments exceeding $1.5 billion

FDA approves Pfizer's hemophilia drug

The approval marks the first non-factor, once-weekly treatment available for hemophilia B without inhibitors

Catalent to sell NJ manufacturing facility to Ardena

The sale includes Catalent’s oral solids development site, and is expected to close early next year

Exclusives

Pharma events calendar

Keep track of in-person industry events.

Pharma Innovation Awards

Now accepting submissions for 2024!

Funny Pharm

Submit your caption to cartoons created by award-winning artist Jerry King.

Articles

The latest content from industry thought leaders.

Editors' (re)View

Weekly takes on things going on in the pharma world.

eBooks & Reports

Sponsored Content

The Strategic Advantages of X-ray Fluorescence for Pharmaceutical Elemental Analysis

X-Ray Fluorescence (XRF) technology streamlines elemental impurity screening, offering faster, cost-effective, and resource-efficient alternatives to traditional ICP methods in...

Sponsored Content

Real-time compliance in pharmaceutical waters

Proper and thorough monitoring of pharmaceutical water systems is imperative to prevent undetected issues from shutting down production and to deliver the highest quality products...

Sponsored Content

4 key compendial measurements for pharma water compliance

A fundamental aspect of pharmaceuticals manufacturing is the production of purified waters that meet pharmacopeia regulations. For continuous assurance of water quality, on-line...

Sponsored Content

Flow imaging microscopy: Transforming biopharmaceutical particle analysis

Discover the power of Flow Imaging Microscopy in biopharmaceuticals. Learn how FIM works and how it can uncover details in your samples, enhancing the characterization of API ...

Sponsored Content

eBook: Supply chain trends

Supply chain challenges have long been a reality for pharma manufacturers, but the pandemic underscored the critical need for enhanced visibility and control. Added pressures,...

eBook: Reshoring manufacturing: Progress and challenges

A collective analysis of reshoring efforts across several major manufacturing industries

Production

Embracing single-use innovations in a post-COVID era

Continued growth and standardization will depend on suppliers innovating to overcome challenges

Curbing pharma warehouse storage expansion with ASRS

Keeping pace with pharma packaging

Batch process understanding for process validation and quality control

Development

Strengthening pharma’s sustainability foundation

New tools can help seamlessly integrate sustainability into R&D and production goals

Vaccines of the future

There is a new era of vaccinology in pharma's pipelines

Excipient-based strategies to harness complex therapeutics

Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.